Rafael Holdings Inc (RFL)
2.07 unch (unch) 01/22/25 [NYSE]
1.87 x 200 3.31 x 200
Realtime by (Cboe BZX)
1.87 x 200 3.31 x 200
Realtime - - (-) -
for Wed, Jan 22nd, 2025
Results
download Want to compare other data? Select FieldsSymbol | RFL | GANX | ALVR | ||
Company | Rafael Holdings Inc | Gain Therapeutics Inc | Allovir Inc | ||
Price Information | |||||
Exchange | NYSE | NASDAQ | NASDAQ | ||
Open | 2.07 | 2.20 | 9.66 | ||
High | 2.10 | 2.25 | 9.66 | ||
Low | 2.00 | 2.06 | 8.88 | ||
Last | 2.07 | 2.13 | 9.20 | ||
Change | unch | -0.05 | -0.18 | ||
% Change | unch | -2.29% | -1.92% | ||
Volume | 77,600 | 119,700 | 38,200 | ||
20-Day Average Volume | 45,600 | 248,725 | 33,202 | ||
Previous Close | 2.07 | 2.18 | 9.38 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 1.88 | 2.10 | 9.96 | ||
20-Day Raw Stochastic | 95.00% | 54.80% | 31.00% | ||
20-Day Relative Strength | 58.30% | 52.47% | 38.28% | ||
Weighted Alpha | +23.30 | -56.24 | -41.12 | ||
Today's Opinion | 96% Buy | 72% Buy | 100% Sell | ||
Previous Opinion | 88% Buy | 72% Buy | 100% Sell | ||
Last Month's Opinion | 24% Buy | 64% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +10.11% since 01/14/25 | +2.40% since 01/14/25 | unch since 01/14/25 | ||
Low | 1.85 on 01/15/25 | 2.03 on 01/21/25 | 7.96 on 01/16/25 | ||
High | 2.10 on 01/22/25 | 2.47 on 01/17/25 | 10.35 on 01/15/25 | ||
1-Month | |||||
%Chg | +6.15% since 12/20/24 | +36.54% since 12/20/24 | -0.99% since 12/20/24 | ||
Low | 1.50 on 12/30/24 | 1.54 on 12/24/24 | 7.96 on 01/16/25 | ||
High | 2.10 on 01/22/25 | 2.65 on 01/02/25 | 11.96 on 01/07/25 | ||
3-Month | |||||
%Chg | +14.36% since 10/22/24 | -20.82% since 10/22/24 | -48.56% since 10/22/24 | ||
Low | 1.50 on 12/30/24 | 1.50 on 12/20/24 | 7.96 on 01/16/25 | ||
High | 2.10 on 01/22/25 | 2.80 on 10/23/24 | 24.15 on 11/04/24 | ||
6-Month | |||||
%Chg | +35.29% since 07/22/24 | +83.62% since 07/22/24 | -47.26% since 07/22/24 | ||
Low | 1.33 on 08/15/24 | 0.89 on 08/13/24 | 7.96 on 01/16/25 | ||
High | 2.50 on 10/14/24 | 3.19 on 10/17/24 | 24.15 on 11/04/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 51,075 | 57,824 | 47,155 | ||
Shares Outstanding, K | 24,674 | 26,525 | 5,027 | ||
Annual Sales | 640,000 | 60,000 | 0 | ||
Annual Net Income | -34,410,000 | -22,270,000 | -190,420,000 | ||
Last Quarter Sales | 130,000 | 0 | 0 | ||
Last Quarter Net Income | -9,010,000 | -4,490,000 | -4,130,000 | ||
60-Month Beta | 1.09 | 0.14 | 0.65 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.37 on 12/11/24 | -0.17 on 11/14/24 | -0.92 on 11/12/24 | ||
Latest Earnings Date | 03/12/25 | 11/12/24 | 11/14/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |